NCT01420861View on ClinicalTrials.gov

GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Prostate Cancer
Interventions
DRUG

GTx-758

two GTx 758 tablets per day

Trial Locations (7)

13210

GTx Investigative Site, Syracuse

19004

GTx Investigative Site, Bala-Cynwyd

23462

GTx Investigative Site, Virginia Beach

47130

GTx Investigational Site, Jeffersonville

78229

GTx Investigative Site, San Antonio

87109

GTx Investigative Site, Albuquerque

92404

GTx Investigative Site, San Bernardino

Sponsors

Lead Sponsor

GTx
All Listed Sponsors
lead

GTx

INDUSTRY

NCT01420861 - GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer | Biotech Hunter | Biotech Hunter